Could the extremely old management be a reason for the low valuation? CEO age 77, COO age 71 ... and other mangers also all above 70. A bit strange ... can such a management bring any innovation? Any thoughts on that issue?
You write "high profit margins". Compared to other medical device manufacturers, their margins are average at best. What makes you say they are "high"?
They have roughly 40% of their balance sheet in cash. What will they do with that cash? As long as it just sits on their balance sheet, there is a) risk of bad allocation and b) 40% of an investment in non-profit making assets.
Out of curiosity - have you tried contacting IR with these questions?
Could the extremely old management be a reason for the low valuation? CEO age 77, COO age 71 ... and other mangers also all above 70. A bit strange ... can such a management bring any innovation? Any thoughts on that issue?
Please allow me two questions.
You write "high profit margins". Compared to other medical device manufacturers, their margins are average at best. What makes you say they are "high"?
They have roughly 40% of their balance sheet in cash. What will they do with that cash? As long as it just sits on their balance sheet, there is a) risk of bad allocation and b) 40% of an investment in non-profit making assets.